A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/495 (2006.01) A61K 31/4985 (2006.01)
Patent
CA 2226784
The use of compounds of formula (I) (6R, 12aR)-2,3,6,7,12,12a-hexahydro-2-methyl- 6-(3,4-methylenedioxyphenyl)-pyrazino[2',1': 6,1]pyrido[3,4-b]indole-1,4-dione, (3S, 6R, 12aR)-2,3,6,7,12,12a-hexahydro-2,3-dimethyl- 6-(3,4-methylenedioxyphenyl)-pyrazino[2',1': 6,1]pyrido[3,4-b]indole-1,4-dione, and physiologically acceptable salts and solvates thereof, in the treatment of impotence.
Utilisation de (6R, 12aR)-2,3,6,7,12,12a-hexahydro-2-méthyl-6-(3,4-méthylènedioxyphényl)-pyrazino[2',1': 6,1]pyrido[3,4-b]indole-1,4-dione, (3S, 6R, 12aR)-2,3,6,7,12,12a-hexahydro-2,3-diméthyl-6-(3,4-méthylènedioxyphényl)-pyrazino [2',1': 6,1]pyrido[3,4-b]indole-1,4-dione, et ses sels et solvates acceptables sur le plan physiologique, dans le traitement de l'impuissance.
Icos Corporation
Smart & Biggar
LandOfFree
Use of cgmp-phosphodiesterase inhibitors to treat impotence does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of cgmp-phosphodiesterase inhibitors to treat impotence, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of cgmp-phosphodiesterase inhibitors to treat impotence will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1569529